Comprehensive community care has the potential to improve risk factor management of patients with stroke or transient ischaemic attack.
Aim
The primary aim is to determine the effectiveness of an individualized management program on risk factor management for patients discharged from hospital after stroke.
Design
Multicentre, cluster-randomized, controlled trial, with clusters by general practice. Participants are randomized to receive intervention or control after a baseline assessment undertaken after discharge from hospital. The general practice they attend is marked as an intervention or control accordingly. All subsequent participants attending those practices are automatically assigned as intervention or control. Baseline and all outcome assessments, including an analysis of risk factors, are undertaken by assessors blinded to patient randomization.
Intervention Details
Based on the results of blinded assessments, the individualized management program group will receive targeted advice on how to manage their risk factors using a standardized, evidence-based template to communicate ‘ideal’ management with their general practitioner. In addition, patients randomized to the individualized management program group will receive counselling and education about stroke risk factor management by an intervention study nurse. Individualized management programs will be reviewed at three-months, six-months, 12 months, and 18 months after stroke, at which times they will be modified if appropriate. Stroke risk management will be evaluated using changes in the Framingham cardiovascular risk score. Analysis will be on an intention-to-treat basis using analysis of covariance or generalized linear model to adjust for baseline risk score and other relevant confounding factors.
TouzeEVarenneOChatellierGPeyrardSRothwellPMMasJ-L. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: A systematic review and meta-analysis. Stroke2005; 36: 2748–55.
2.
HardieKHankeyGJJamrozikKBroadhurstRJAndersonC. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke2004; 35: 731–5.
3.
VickreyBGRectorTSWickstromSL. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke2002; 33: 901–6.
4.
LovettJKDennisMSSandercockPAGBamfordJWarlowCPRothwellPM. Very early risk of stroke after a first transient ischemic attack. Stroke2003; 34: e138–40.
5.
ThriftAGDeweyHMMacdonellRALMcNeilJJDonnanGA. Stroke incidence on the east coast of Australia: The North East Melbourne Stroke Incidence Study (NEMESIS). Stroke2000; 31: 2087–92.
SenesS. How we manage stroke in Australia. Australian Institute of Health and Welfare cat no CVD 31, 2006.
8.
WolfPAD'AgostinoRBBelangerAJKannelWB. Probability of stroke: A risk profile from the Framingham Study. Stroke1991; 22: 312–18.
9.
RashidPLeonardi-BeeJBathP. Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review. Stroke2003; 34: 2741–8.
10.
Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ2002; 324: 71–86.
11.
SaxenaRKoudstaalP. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev2004; (4): CD000187.
12.
SaxenaRKoudstaalPJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev2004; (2): CD000185.
13.
JulaAMarniemiJHuupponenRVirtanenARastasMRonnemaaT. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: A randomized controlled trial. JAMA2002; 287: 598–605.
14.
RubakSSandbaekALauritzenTChristensenB. Motivational interviewing: A systematic review and meta-analysis. Br J Gen Pract2005; 55: 305–12.
15.
BeckmanJACreagerMALibbyP. Diabetes and atherosclerosis. JAMA2002; 287: 2570–81.
16.
ThomasDEElliottEJNaughtonGA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev2006; (3): CD002968.
17.
SchroederKFaheyTEbrahimS. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev2004; (2): CD004804.
18.
SchedlbauerASchroederKPetersTJFaheyT. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev2004; (4): CD004371.
19.
WannametheeSGShaperAGWhincupPHWalkerM. Smoking cessation and the risk of stroke in middle-aged men. JAMA1995; 274: 155–60.
20.
KawachiIColditzGAStampferMJ. Smoking cessation and decreased risk of stroke in women. JAMA1993; 269: 232–6.
21.
HooperLSummerbellCDHigginsJP. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev2001; (3): CD002137.
22.
JurgensGGraudalNA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev2004; (1);CD004022.
23.
HeFJMacGregorGA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev2004; (3): CD004937.
24.
HeFJNowsonCAMacGregorGA. Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet2006; 367: 320–6.
25.
WheltonSPChinAXinXHeJ. Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials. Ann Intern Med2002; 136: 493–503.
26.
ReynoldsKLewisBNolenJDKinneyGLSathyaBHeJ. Alcohol consumption and risk of stroke: A meta-analysis. JAMA2003; 289: 579–88.
CadilhacDACarterRCThriftAGDeweyHM. Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Health Policy2007; 83: 287–94.
31.
BakSSindrupSHAlslevTKristensenOChristensenKGaistD. Cessation of smoking after first-ever stroke: A follow-up study. Stroke2002; 33: 2263–9.
32.
RendersCMValkGDGriffinSWagnerEHEijkJTAssendelftWJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev2001; (1): CD001481.
33.
FaheyTSchroederKEbrahimS. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev2006; (2): CD005182.
D'AgostinoRBSrVasanRSPencinaMJ. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation2008; 117: 743–53.
36.
HarwoodRHRogersADickinsonEEbrahimS. Measuring handicap: The London Handicap Scale, a new outcome measure for chronic disease. Qual Health Care1994; 3: 11–6.
37.
JohnstonMPollardBHennesseyP. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res2000; 48: 579–84.
38.
SturmJWOsborneRHDeweyHMDonnanGAMacdonellRALThriftAG. Brief comprehensive quality of life assessment after stroke. Stroke2002; 33: 2888–94.
39.
BanksJLMarottaCA. Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials. Stroke2007; 38: 1091–6.
40.
O'BrienEAsmarRBeilinL. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens2003; 21: 821–48.
41.
DeweyHMThriftAGMihalopoulosC. Cost of stroke in Australia from a societal perspective. Stroke2001; 32: 2409–16.
42.
TengsTOYuMLuistroE. Health-related quality of life after stroke a comprehensive review. Stroke2001; 32: 964–72.
43.
HabyMMCarterRMihalopoulosC. Assessing cost-effectiveness – mental health: Introduction to the study and methods. Aust N Z J Psychiatry2004; 38: 569–78.
